IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,000 | +106283.0% | 51,000 | +8.5% | 0.00% | 0.0% |
Q2 2023 | $47 | 0.0% | 47,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $47 | -6.0% | 47,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $50 | -99.9% | 47,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $47,000 | +161.1% | 47,000 | +176.5% | 0.00% | +200.0% |
Q2 2022 | $18,000 | -5.3% | 17,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $19,000 | +72.7% | 17,000 | +70.0% | 0.00% | 0.0% |
Q4 2021 | $11,000 | -8.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $12,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 5,300,000 | $6,265,000 | 0.59% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,457,000 | $5,272,000 | 0.40% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $12,314,000 | 0.28% |
AQR Arbitrage LLC | 7,700,000 | $9,119,000 | 0.26% |
WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $25,018,000 | 0.22% |
LINDEN ADVISORS LP | 26,849,000 | $31,752,000 | 0.19% |
HBK INVESTMENTS L P | 10,000,000 | $11,822,000 | 0.05% |
Calamos Advisors LLC | 7,500,000 | $8,910,000 | 0.04% |
Jefferies Group LLC | 3,245,000 | $3,856,677 | 0.03% |
CAPSTONE INVESTMENT ADVISORS, LLC | 9,700,000 | $11,487,000 | 0.02% |